MENU
CLHIA asks for strategies on expensive drugs and retirement plans

Access to expensive drugs and finding solutions to secure retirement income products are on the top of the pre-budget wi…

LIFE INSURANCE | February 05 2020 11:01AM
Pharmaceutical treatments lacking

The term "orphan" appeared in the early 1980s in the United States in connection with the treatment of rare diseases. It…

HEALTH | January 22 2020 02:39PM
Rare and orphan diseases: a challenge for individuals and society

There are more than 7,000 around the world. Sometimes they only affect a few dozen people. Their treatment costs a fortu…

HEALTH | January 22 2020 01:40PM
Pharmacare plan for Canadians still a question mark

A national pharmacare plan for Canadians holds as many unanswered questions now as it did before the federal election wi…

HEALTH | November 07 2019 01:40PM
Pharmaceutical company advocates for more accessible healthcare

McKesson Canada President Paula Keays is appealing to the pharmaceutical and medical industry to improve accessibility t…

HEALTH | November 05 2019 10:06AM
Advertisement
Biosimilars: British Columbia extends transition program

Rising drug costs are plaguing public and private health insurance plans alike. In response to this trend, British Colum…

HEALTH | October 03 2019 11:14AM
Public drug plan spending on the rise

A new report by the Patented Medicine Prices Review Board (PMPRB) reveals that prescription drug expenditures by Canadia…

HEALTH | September 09 2019 11:30AM